Fractyl Health Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 84

Employees

  • Stock Symbol
  • GUTS

Stock Symbol

  • Share Price
  • $1.51
  • (As of Friday Closing)

Fractyl Health General Information

Description

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Contact Information

Website
www.fractyl.com
Formerly Known As
MedCatalyst, Fractyl Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 3 Van de Graaff Drive
  • Suite 200
  • Burlington, MA 01803
  • United States
+1 (720)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Therapeutic Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 3 Van de Graaff Drive
  • Suite 200
  • Burlington, MA 01803
  • United States
+1 (720)

Fractyl Health Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fractyl Health Stock Performance

As of 07-Feb-2025, Fractyl Health’s stock price is $1.51. Its current market cap is $72.6M with 48.1M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.51 $1.61 $1.51 - $10.50 $72.6M 48.1M 353K -$1.58

Fractyl Health Financials Summary

As of 30-Sep-2024, Fractyl Health has a trailing 12-month revenue of $97K.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 80,041
Revenue 97 120 0 0
EBITDA (66,295) (78,065) (46,798) (36,617)
Net Income (62,904) (77,091) (46,453) (38,735)
Total Assets 126,924 76,212 60,956 102,548
Total Debt 62,931 86,391 19,475 17,008
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Fractyl Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Fractyl Health‘s full profile, request access.

Request a free trial

Fractyl Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Fractyl Health‘s full profile, request access.

Request a free trial

Fractyl Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metaboli
Biotechnology
Burlington, MA
84 As of 2023

Bagsvaerd, Denmark
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fractyl Health Competitors (23)

One of Fractyl Health’s 23 competitors is Novo Nordisk, a Corporation company based in Bagsvaerd, Denmark.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novo Nordisk Corporation Bagsvaerd, Denmark
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
Carmot Therapeutics Formerly VC-backed Berkeley, CA
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Boehringer Ingelheim Corporation Ingelheim Am Rhein, Germany
You’re viewing 5 of 23 competitors. Get the full list »

Fractyl Health Patents

Fractyl Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022419348-A1 Methods and systems for treating mucosal dysfunction and other medical conditions of a patient Pending 22-Dec-2021
AU-2022414072-A1 Gene therapies for metabolic disorders Pending 15-Dec-2021
EP-4447986-A1 Gene therapies for metabolic disorders Pending 15-Dec-2021
AU-2022219999-A1 System for treating a patient Pending 11-Feb-2021
EP-4291262-A1 System for treating a patient Pending 11-Feb-2021 A61K9/0019
To view Fractyl Health’s complete patent history, request access »

Fractyl Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fractyl Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Fractyl Health‘s full profile, request access.

Request a free trial

Fractyl Health FAQs

  • When was Fractyl Health founded?

    Fractyl Health was founded in 2010.

  • Where is Fractyl Health headquartered?

    Fractyl Health is headquartered in Burlington, MA.

  • What is the size of Fractyl Health?

    Fractyl Health has 84 total employees.

  • What industry is Fractyl Health in?

    Fractyl Health’s primary industry is Biotechnology.

  • Is Fractyl Health a private or public company?

    Fractyl Health is a Public company.

  • What is Fractyl Health’s stock symbol?

    The ticker symbol for Fractyl Health is GUTS.

  • What is the current stock price of Fractyl Health?

    As of 07-Feb-2025 the stock price of Fractyl Health is $1.51.

  • What is the current market cap of Fractyl Health?

    The current market capitalization of Fractyl Health is $72.6M.

  • What is Fractyl Health’s current revenue?

    The trailing twelve month revenue for Fractyl Health is $97K.

  • Who are Fractyl Health’s competitors?

    Novo Nordisk, Dicerna Pharmaceuticals, Carmot Therapeutics, Sarepta Therapeutics, and Boehringer Ingelheim are some of the 23 competitors of Fractyl Health.

  • What is Fractyl Health’s annual earnings per share (EPS)?

    Fractyl Health’s EPS for 12 months was -$1.58.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »